<DOC>
	<DOCNO>NCT00839293</DOCNO>
	<brief_summary>The purpose study evaluate safety compare bioavailability fenofibric acid 2 different dosage strengths ABT-335 .</brief_summary>
	<brief_title>Comparison Fenofibric Acid Bioavailability From ABT-335 Capsules</brief_title>
	<detailed_description />
	<mesh_term>Fenofibric acid</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>A condition general good health BMI 18 29 Currently enrol another clinical study Females pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Bioavailability</keyword>
</DOC>